Concise Prescribing Info
Prevention of artherothrombotic events eg, recent MI, stroke, established peripheral arterial disease; acute coronary syndrome; patients suffering from MI (from few days until <35 days), ischaemic strokes (from 7 days until <6 mth); non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave MI) including patients undergoing stent replacement following percutaneous coronary intervention. In combination w/ ASA for ST segment elevation acute MI in medically treated-patients & eligible for thrombolytic therapy.
Dosage/Direction for Use
Adult & elderly 75 mg as single daily dose. Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave MI) Initially 300 mg as single loading dose then continued at 75 mg once daily w/ ASA 75-325 mg daily. ST segment elevation acute MI 75 mg as single daily dose initiated w/ loading dose in combination w/ ASA & w/ or w/o thrombolytics.
May be taken with or without food.
Hypersensitivity. Active pathological bleeding eg, peptic ulcer or intracranial hemorrhage. Severe hepatic impairment. Lactation.
Special Precautions
Genetically reduced CYP22C19 function (intermediate or poor metabolisers); unusual bleeding; if bleeding occurs during the course of treatment; patients from trauma, surgery or other pathological conditions; lesions w/ propensity to bleed particularly GI & intraocular. Discontinue use 7 days prior to elective surgery. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Renal impairment. Moderate hepatic disease. Pregnancy & lactation.
Adverse Reactions
Eye bleeding (conjunctival, ocular, retinal), haematoma, epistaxis, GI disturbances, bleeding at puncture site, bruising.
Drug Interactions
Reduded clinical efficacy w/ CYP2C19 eg, proton-pump inhibitors. Increased bleeding intensity w/ warfarin & glycoprotein IIb/IIIa inhibitors, heparin & thrombolytics. Increased occult GI blood loss w/ other NSAIDs including COX-2 inhibitors.
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AC04 - clopidogrel ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.
Clovix 75 mg film-coated tab
2 × 14's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in